Histoplasmosis - chronic pulmonary
Fungal infections are caused by microscopic organisms (fungi) that can live on the skin. They can live on the dead tissues of the hair, nails, and outer skin layers.
Also known as: Chronic cavitary histoplasmosis
- Cancer
- Chemotherapy
- Immune-suppressing drugs
- HIV infection
- Chills
- Cough that brings up blood, mucus, or pus
- Fever
- Shortness of breath
- Unintentional weight loss
- Biopsy of infected tissue, such as open lung biopsy
- Bronchoscopy with transbronchial biopsy or bronchoalveolar lavage
- CBC
- Chest CT scan
- Chest x-ray
- Histoplasma complement fixation titer
- Histoplasma urinary antigen test (positive only if the person also has disseminated histoplasmosis)
- Immunodiffusion test
- Sputum culture and stain
- Arthritis
- Disseminated histoplasmosis
- Lung scarring (fibrosis)
- Pericarditis
- Respiratory insufficiency
Definition
Chronic pulmonary histoplasmosis is a long-term respiratory infection caused by breathing the spores of the fungus, Histoplasma capsulatum.
See also:
Causes, incidence, and risk factors
Histoplasma capsulatum is a fungus found in the soil of the central and eastern United States (especially Mississippi and Ohio river valleys), eastern Canada, Mexico, Central America, and South America.
The infection occurs when a person breathes in the reproducing parts of the fungus, called spores. Those who have a healthy immune system usually do not have symptoms, or only mild ones.
This "acute" infection does not last, but can leave a person with small scars (granulomas). These scars can be difficult to distinguish from tumors in the lung.
However, the infection can cause severe illness right away, or redevelop years after the first exposure, if a person's immune system is weakened by:
Risk factors for chronic pulmonary histoplasmosis include:
Symptoms
Signs and tests
Tests that may be used to diagnose chronic pulmonary histoplasmosis include:
Treatment
The doctor will prescribe antifungal medications to control the infection within the lung. These medications must be taken for 1 to 2 years.
Expectations (prognosis)
The infection usually goes away with antifungal medication, but scarring inside the lung often remains. Histoplasmosis is unusual enough that if you develop it, your health care provider should check to find out whether another disease is weakening your immune system.
Often, those who have had chronic pulmonary histoplasmosis must follow up with their doctor, who will check for signs of relapse.
In rare cases, a pulmonary histoplasmosis infection can spread through the blood to other organs. This is called disseminated histoplasmosis. People who have a suppressed immune system and very young children are more likely to develop this condition. If this occurs, the prognosis is less favorable.
Complications
Patients who breathe in a large amount of fungus can develop a severe and potentially deadly and sudden type of lung infection.
Calling your health care provider
Call for an appointment with your health care provider if you develop symptoms of chronic pulmonary histoplasmosis.
Call your health care provider if your symptoms continue despite treatment, or if you have breathing difficulty or symptoms of disseminated histoplasmosis.
Prevention
Be aware of your surroundings, especially if you are in a weakened state from another medical condition, or from immune-suppressing medications.
References
Kauffman CA. Histoplasmosis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 353.
What LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis, 2007;45(7):807-825.
- Review date:
- December 1, 2009
- Reviewed by:
- David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Copyright Information
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.




















